Interleukin-6 and interleukin-8 serum levels in prognosis of hormone-dependent breast cancer.
CONCLUSIONS: This study contributes to the clarification of the prognostic performance of IL6 and IL8 by providing their first prognostic evaluation in the homogenized ER+ breast cancer patient group. IL6 was indicated as a marker of favorable, whereas IL8 was a marker of unfavorable disease outcome.
PMID: 29482885 [PubMed - as supplied by publisher]
Source: Cytokine - Category: Molecular Biology Authors: Milovanović J, Todorović-Raković N, Radulovic M Tags: Cytokine Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | HER2 | Hormonal Therapy | Hormones | Molecular Biology | Study | Tamoxifen | Women